Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Promethazine
Cat. No.:
OB0225LY-0126
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Promethazine is an antihistamine and sedative that belongs to the phenothiazine class of drugs.
Synonym:
Proazamine; Diphergan; 60-87-7; Vallergine; Dimapp; Fargan; (2-Dimethylamino-2-methyl)ethyl-N-dibenzoparathiazine; Dimethylamino-isopropyl-phenthiazin; 10-(2-Dimethylaminopropyl)phenothiazine; N-Dimethylamino-2-methylethyl thiodiphenylamine
CAS No.:
60-87-7
Compound CID:
4927
Formula:
C17H20N2S
Formula Weight:
284.42
Specification
Relative Density:
1.131 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Promethazine plays an important role in studies of symptomatic relief of allergy symptoms, motion sickness, pre-surgical drug sedation, and relief of nausea and vomiting.
Library Information
Targets:
Histamine receptors; G protein-coupled receptors (GPCRs); Serine/Threonine kinases
Receptors:
Histamine H1 receptor; Muscarinic receptors; Dopamine D2 receptor; Adrenergic α1 receptor; 5-HT receptor subtypes; CaMK II
Pathways:
GPCR/G protein; Immunology/Inflammation; Neuronal signaling
Plate Number:
AOCL-2
Plate Location:
e9
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
11 mg/mL; 38.68 mM
